Celacade™ system

DEVICE2 trials

Sponsors

Vasogen

Conditions

Arterial Occlusive DiseasesHeart Failure, CongestiveIntermittent ClaudicationPeripheral Arterial Disease

Phase 3

SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes

TerminatedNCT00111826

VasogenArterial Occlusive Diseases, Intermittent Claudication, Peripheral Arterial Disease

Start: 2003-01-31End: 2005-12-31Target: 500Updated: 2010-03-31

ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy

CompletedNCT00111969

VasogenHeart Failure, Congestive

Start: 2003-06-30End: 2005-11-30Target: 2016Updated: 2006-07-04

Related Papers

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.

2008-01-01137 citations